Searching in EMA · Search everything
1 change Guidance, last 7 days
EMA PRAC Warns of Aseptic Meningitis Risk with Ixchiq Vaccine
The EMA's Pharmacovigilance Risk Assessment Committee (PRAC) has recommended updating the product information for the chikungunya vaccine Ixchiq to reflect recent evidence of aseptic meningitis risk, particularly in healthy young adults. This follows a safety signal investigation and is part of a regular safety assessment.
Priority review
Guidance
Pharmaceuticals
Get alerts for ""
We'll email you when new changes match this search.
Free. Unsubscribe anytime.